Fukuoka, Japan

Shirou Mawatari

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Marudai Food Co., Ltd.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shirou Mawatari. Retrieved from https://idiyas.com/inventor/shirou-mawatari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Shirou Mawatari

Introduction

Shirou Mawatari is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of neuroscience through his innovative work. His research focuses on developing new substances that can aid in the regeneration of cerebral nerve cells.

Latest Patents

Mawatari holds a patent for a cerebral nerve cell neogenesis agent. The objective of this invention is to provide a new substance that has a cerebral nerve cell neogenesis effect. This agent is particularly effective in treating and preventing neurological disorders. The invention features a cerebral nerve cell neogenesis agent that contains a plasmalogen as an active ingredient. Specifically, it includes a biological tissue extracted plasmalogen, primarily consisting of ethanolamine plasmalogen and choline plasmalogen. He has 1 patent to his name.

Career Highlights

Shirou Mawatari is associated with Marudai Food Co., Ltd., where he continues to pursue his research and development efforts. His work has garnered attention for its potential applications in medical science, particularly in neurology.

Collaborations

Mawatari has collaborated with notable colleagues such as Hidetaka Fuchu and Keita Yunoki. Their combined expertise has contributed to the advancement of their research projects.

Conclusion

Shirou Mawatari's innovative work in developing a cerebral nerve cell neogenesis agent highlights his commitment to advancing neuroscience. His contributions have the potential to make a significant impact on the treatment of neurological disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…